| * Aecom ACM.N: Citigroup raises target price to $152 from $150 |
| * Aecom ACM.N: UBS cuts target price to $148 from $153 |
| * Affirm Holdings Inc AFRM.O: Truist Securities cuts target price to $85 from $90 |
| * Albemarle ALB.N: BMO raises target price to $136 from $125 |
| * Amalgamated Financial AMAL.O: Piper Sandler raises target price to $28 from $27 |
| * Amalgamated Financial AMAL.O: Piper Sandler raises to neutral from underweight |
| * Amentum Holdings Inc AMTM.N: UBS initiates coverage with neutral rating and PT $25 |
| * American Battery Technology Co ABAT.O: Alliance Global Partners ups PT to $7 from $6 |
| * American Eagle Outfitters Inc AEO.N: UBS raises target price to $22 from $21.50 |
| * Amgen Inc AMGN.O: HSBC raises target price to $381 from $343 |
| * Anavex Life Sciences Corp. AVXL.O: H.C. Wainwright cuts target price to $20 from $42 |
| * Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises PT to $44 from $23 |
| * Arrowhead Pharmaceuticals ARWR.O: Piper Sandler raises target price to $70 from $45 |
| * Arrowhead Pharmaceuticals ARWR.O: RBC raises target price to $52 from $45 |
| * Artelo Biosciences Inc ARTL.O: Maxim Group cuts to hold from buy |
| * Baidu Inc BIDU.O: Jefferies raises target price to $159 from $157 |
| * Bank of America BAC.N: Oppenheimer cuts target price to $55 from $57 |
| * Bellring Brands Inc BRBR.N: Bernstein cuts target price to $38 from $46 |
| * Bellring Brands Inc BRBR.N: BofA Global Research cuts price objective to $28 from $50 |
| * Bellring Brands Inc BRBR.N: BofA Global Research cuts to neutral from buy |
| * Bellring Brands Inc BRBR.N: Deutsche Bank cuts target price to $35 from $38 |
| * Bellring Brands Inc BRBR.N: Jefferies cuts target price to $48 from $52 |
| * Bellring Brands Inc BRBR.N: JP Morgan cuts target price to $36 from $45 |
| * Bellring Brands Inc BRBR.N: Morgan Stanley cuts target price to $41 from $43 |
| * Bellring Brands Inc BRBR.N: Stifel cuts target price to $50 from $56 |
| * Bill Holdings Inc BILL.N: Truist Securities cuts target price to $60 from $61 |
| * Boston Omaha Corp BOC.N: TD Cowen cuts target price to $20 from $22 |
| * Cartesian Therapeutics Inc RNAC.O: H.C. Wainwright cuts target price to $30 from $40 |
| * Citigroup Inc C.N: Oppenheimer cuts target price to $120 from $123 |
| * Coty Inc COTY.N: Berenberg cuts target price to $4.20 from $5.05 |
| * CrowdStrike CRWD.O: Jefferies raises target price to $600 from $515 |
| * Curbline Properties Corp. CURB.N: Citigroup raises target price to $27 from $25 |
| * Curbline Properties Corp. CURB.N: Citigroup raises to buy from neutral |
| * Dick's Sporting Goods Inc DKS.N: JP Morgan cuts target price to $228 from $235 |
| * Dolby Laboratories Inc DLB.N: Rosenblatt Securities cuts target price to $85 from $95 |
| * DoorDash DASH.O: Jefferies raises to buy from hold; raises PT to $260 from $220 |
| * Dow Inc DOW.N: Citigroup cuts target price to $23 from $25 |
| * Dynatrace Inc DT.N: Truist Securities cuts target price to $55 from $60 |
| * Elanco Animal Health Inc ELAN.N: Argus Research raises to buy from hold |
| * Eli Lilly LLY.N: Truist Securities raises target price to $1,182 from $1,038 |
| * Energizer Holdings Inc ENR.N: Canaccord Genuity cuts target price to $20 from $29 |
| * Energizer Holdings Inc ENR.N: JP Morgan cuts target price to $23 from $28 |
| * Extreme Networks Inc EXTR.O: BofA Global Research initiates coverage with buy rating |
| * Extreme Networks Inc EXTR.O: BofA Global Research initiates coverage with PT $24 |
| * FIS FIS.N: Truist Securities cuts target price to $70 from $72 |
| * Freeport-Mcmoran Inc FCX.N: BMO cuts target price to $47 from $48 |
| * Freeport-Mcmoran Inc FCX.N: HSBC cuts target price to $48 from $50 |
| * Freeport-Mcmoran Inc FCX.N: Raymond James cuts target price to $45 from $46 |
| * Freeport-Mcmoran Inc FCX.N: Scotiabank cuts target price to $47 from $51 |
| * Freeport-Mcmoran Inc FCX.N: Scotiabank raises to sector outperform from sector perform |
| * Gitlab Inc GTLB.O: Truist Securities cuts target price to $44 from $55 |
| * Gitlab Inc GTLB.O: Truist Securities cuts to hold from buy |
| * Gladstone Capital Corp GLAD.O: B. Riley cuts target price to $22 from $27 |
| * Gladstone Capital Corp GLAD.O: B. Riley raises to buy from neutral |
| * Gladstone Capital Corp GLAD.O: Oppenheimer cuts target price to $22 from $26 |
| * Gladstone Capital Corp GLAD.O: Oppenheimer raises to outperform from perform |
| * GoHealth Inc GOCO.O: William Blair cuts to market perform rating |
| * Helmerich and Payne Inc HP.N: Susquehanna raises target price to $31 from $26 |
| * Highwoods Properties Inc HIW.N: Truist Securities cuts target price to $31 from $33 |
| * Hilton Worldwide HLT.N: Bernstein cuts target price to $285 from $288 |
| * Home Depot Inc HD.N: Bernstein cuts target price to $362 from $406 |
| * Home Depot Inc HD.N: BofA Global Research cuts price objective to $430 from $450 |
| * Home Depot Inc HD.N: D.A. Davidson cuts target price to $430 from $475 |
| * Home Depot Inc HD.N: HSBC cuts target price to $400 from $445 |
| * Home Depot Inc HD.N: Jefferies cuts target price to $438 from $474 |
| * Home Depot Inc HD.N: JP Morgan cuts target price to $423 from $444 |
| * Home Depot Inc HD.N: Mizuho cuts target price to $400 from $450 |
| * Home Depot Inc HD.N: Morgan Stanley cuts target price to $395 from $430 |
| * Home Depot Inc HD.N: RBC cuts target price to $376 from $401 |
| * Home Depot Inc HD.N: Telsey Advisory Group cuts target price to $430 from $455 |
| * Home Depot Inc HD.N: Truist Securities cuts target price to $379 from $421 |
| * Home Depot Inc HD.N: UBS cuts target price to $445 from $475 |
| * Horizon Technology Finance Corp HRZN.O: UBS raises target price to $6.50 from $6.25 |
| * Hyatt Hotels Corp H.N: Bernstein raises target price to $188 from $177 |
| * Incyte INCY.O: Jefferies raises target price to $120 from $102 |
| * Insight Enterprises Inc NSIT.O: Canaccord Genuity initiates coverage with hold rating |
| * Insight Enterprises Inc NSIT.O: Canaccord Genuity initiates coverage with PT $100 |
| * Insulet Corp PODD.O: UBS raises target price to $400 from $355 |
| * Insulet Corp PODD.O: UBS raises to buy from neutral |
| * Interparfums Inc IPAR.O: Jefferies cuts target price to $100 from $115 |
| * Intuitive Machines Inc LUNR.O: BofA Global Research raises PT to $9.50 from $8.50 |
| * Ionis Pharmaceuticals Inc IONS.O: Leerink Partners raises target price to $85 from $83 |
| * J M Smucker Co SJM.N: JP Morgan cuts target price to $122 from $126 |
| * Jazz Pharmaceuticals Plc JAZZ.O: Truist Securities raises target price to $220 from $205 |
| * Kinetik Holdings Inc KNTK.N: RBC cuts target price to $46 from $52 |
| * LGI Homes Inc LGIH.O: JP Morgan cuts target price to $40 from $48.50 |
| * LifeMD Inc LFMD.O: H.C. Wainwright cuts target price to $9 from $13 |
| * Madrigal Pharmaceuticals Inc MDGL.O: Truist Securities raises PT to $640 from $580 |
| * Marriott MAR.O: Bernstein raises target price to $329 from $327 |
| * MBIA Inc MBI.N: KBW raises target price to $8.5 from $8 |
| * Merck & Co Inc MRK.N: Berenberg raises target price to $95 from $90 |
| * Micron Technology Inc MU.O: TD Cowen raises target price to $275 from $200 |
| * Nuvalent Inc NUVL.O: JP Morgan raises target price to $147 from $125 |
| * Nuvation Bio Inc NUVB.N: B. Riley initiates coverage with buy rating; target price $12 |
| * Olema Pharmaceuticals Inc OLMA.O: JP Morgan raises target price to $55 from $32 |
| * PagerDuty Inc PD.N: Truist Securities cuts target price to $20 from $23 |
| * Palmer Square Capital BDC Inc PSBD.N: UBS cuts target price to $13 from $13.50 |
| * Palvella Therapeutics Inc PVLA.O: Raymond James raises target price to $143 from $92 |
| * Palvella Therapeutics Inc PVLA.O: Raymond James raises to strong buy from outperform |
| * Parsons Corp PSN.N: UBS initiates coverage with buy rating and target price $107 |
| * PNC Financial Services Group PNC.N: Oppenheimer cuts target price to $231 from $240 |
| * Portland General Electric Co POR.N: Mizuho raises target price to $51 from $47 |
| * Portland General Electric Co POR.N: UBS cuts to neutral from buy |
| * Praxis Precision Medicines Inc PRAX.O: BTIG initiates coverage with buy rating |
| * Praxis Precision Medicines Inc PRAX.O: BTIG initiates coverage with target price $424 |
| * QuantumScape Corp QS.N: HSBC cuts to reduce from hold |
| * QuantumScape Corp QS.N: HSBC raises target price to $10.50 from $5.30 |
| * Rapport Therapeutics Inc RAPP.O: BTIG initiates coverage with buy rating |
| * Rapport Therapeutics Inc RAPP.O: BTIG initiates coverage with target price $47 |
| * Redwire Corp RDW.N: BofA Global Research cuts price objective to $6 from $9 |
| * Relmada Therapeutics Inc RLMD.O: Mizuho raises target price to $10 from $1 |
| * Relmada Therapeutics Inc RLMD.O: Mizuho raises to outperform from neutral |
| * Rocket Lab Corp RKLB.O: BofA Global Research raises price objective to $60 from $50 |
| * Runway Growth Finance Corp RWAY.O: UBS cuts target price to $12 from $12.50 |
| * Semrush Holdings Inc SEMR.N: Keybanc cuts to sector weight from overweight |
| * SentinelOne Inc S.N: Barclays cuts target price to $18 from $21 |
| * Shift4 Payments Inc FOUR.N: Truist Securities cuts target price to $74 from $80 |
| * Shore Bancshares Inc SHBI.O: Hovde Group initiates coverage with outperform rating |
| * Shore Bancshares Inc SHBI.O: Hovde Group initiates coverage with price target $19 |
| * Sionna Therapeutics Inc SION.O: BTIG initiates coverage with buy rating |
| * Sionna Therapeutics Inc SION.O: BTIG initiates coverage with target price $50 |
| * Tanger Inc SKT.N: Citigroup cuts to neutral from buy; cuts PT to $35 from $38 |
| * Terns Pharmaceuticals Inc TERN.O: Truist Securities raises PT to $35 from $28 |
| * TJX Companies Inc TJX.N: JP Morgan raises target price to $154 from $150 |
| * Trevi Therapeutics Inc TRVI.O: Leerink Partners raises target price to $16 from $13 |
| * Turning Point Brands Inc. TPB.N: Oppenheimer raises target price to $120 from $110 |
| * U.S. Bancorp USB.N: Oppenheimer cuts target price to $64 from $66 |
| * UGI Corp UGI.N: Jefferies raises target price to $45 from $44 |
| * Ultragenyx Pharmaceutical Inc RARE.O: JP Morgan cuts target price to $120 from $125 |
| * Universal Health Services Inc UHS.N: JP Morgan raises target price to $240 from $195 |
| * Upwork Inc UPWK.O: Canaccord Genuity raises target price to $24 from $22 |
| * Upwork Inc UPWK.O: UBS raises target price to $24 from $23 |
| * Varex Imaging VREX.O: Oppenheimer cuts target price to $18 from $23 |
| * Vaxcyte Inc PCVX.O: Leerink Partners raises target price to $77 from $60 |
| * VTV Therapeutics Inc VTVT.O: BTIG initiates coverage with buy rating; target price $40 |
| * Wesco International Inc WCC.N: RBC raises target price to $302 from $262 |
| * Wesco International Inc WCC.N: RBC raises to outperform from sector perform |
| * Westlake Corp WLK.N: Citigroup cuts target price to $75 from $88 |
| * Zions Bancorporation NA ZION.O: Jefferies raises target price to $60 from $55 |
| * Zions Bancorporation NA ZION.O: Jefferies raises to buy from hold |
| * Zymeworks Inc ZYME.O: JP Morgan raises target price to $31 from $23 |
| * Zymeworks Inc ZYME.O: Stifel raises target price to $40 from $30 |
